Role of paraoxonase1 in the regulation of high-density lipoprotein functionality and in cardiovascular protection
A Khalil, T Fulop, H Berrougui - Antioxidants & redox signaling, 2021 - liebertpub.com
Significance: Human paraoxonase (PON) is a member of the gene family that includes
paraoxonase 1 (PON1), PON2, and PON3. PON is known for its capacity to hydrolyze a wide …
paraoxonase 1 (PON1), PON2, and PON3. PON is known for its capacity to hydrolyze a wide …
Serum proteome and metabolome uncover novel biomarkers for the assessment of disease activity and diagnosing of systemic lupus erythematosus
J He, D Tang, D Liu, X Hong, C Ma, F Zheng, Z Zeng… - Clinical …, 2023 - Elsevier
Systemic lupus erythematosus (SLE) is an autoimmune disease affecting thousands of
people. There are still no effective biomarkers for SLE diagnosis and disease activity …
people. There are still no effective biomarkers for SLE diagnosis and disease activity …
Evaluation of Serum Amyloid A and some Biochemical markers in Iraqi patients with systemic lupus erythematosus
ZA Salman - Al-Salam Journal for Medical Science, 2024 - journal.alsalam.edu.iq
An autoimmune condition called systemic lupus erythematosus (SLE) is caused by long-
term inflammation. Amyloid A (AA) amyloidosis results in nephropathy and other internal …
term inflammation. Amyloid A (AA) amyloidosis results in nephropathy and other internal …
Рівень аполіпопротеїну А1 у хворих на цукровий діабет і коморбідні захворювання на тлі COVID-19
LK Sokolova, YB Belchina… - Ендокринологія …, 2021 - endokrynologia.com.ua
Анотація Підвищений рівень холестерину ліпопротеїнів високої щільності (ЛПВЩ) та
аполіпопротеїну А1 (ApoA1) у плазмі асоціюється зі зниженим ризиком розвитку …
аполіпопротеїну А1 (ApoA1) у плазмі асоціюється зі зниженим ризиком розвитку …